Epigenetic targeting of myeloid-derived suppressor cells: time to move into infectious diseases?

Frontiers in Immunology

Immunology

Morten Frier Gjerstorff¹ 

[1] Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark;Department of Oncology, Odense University Hospital, Odense, Denmark;Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark;

关键词: cancer;    MDSC (myeloid-derived suppressor cell);    chronic infection;    epigenetic inhibitor;    inflammation;   

DOI  :  10.3389/fimmu.2023.1247715

 received in 2023-07-11, accepted in 2023-08-14,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Gjerstorff